AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTES AND WARRANTSNotes and Warrants • February 3rd, 2010 • Huifeng Bio-Pharmaceutical Technology, Inc. • Medicinal chemicals & botanical products
This Amendment to Secured Convertible Promissory Notes and Warrants (this “Agreement”) is entered into by and between Huifeng Bio-Pharmaceutical Technology, Inc., a Nevada Corporation (the “Company), and each of those persons and entities, severally and not jointly, whose names are set forth on the Schedule of Lenders attached hereto as Exhibit A (which persons and entities are hereinafter collectively referred to as “Lenders” and each individually as a “Lender”) on the 24th day of December, 2009 (the “Effective Date”), amending certain provisions of those certain Secured Convertible Promissory Notes dated December 31, 2007 (each, a “Note” and together, the “Notes”) and those certain Warrants dated December 31, 2007 (each a “Warrant” and together, the “Warrants”). All capitalized terms used, but not defined herein, shall have the meanings given to them in the Notes.
